63 related articles for article (PubMed ID: 14982566)
1. Analgesic effect of dextromethorphan in neuropathic pain.
Carlsson KC; Hoem NO; Moberg ER; Mathisen LC
Acta Anaesthesiol Scand; 2004 Mar; 48(3):328-36. PubMed ID: 14982566
[TBL] [Abstract][Full Text] [Related]
2. Central Sensitization, N-methyl-D-aspartate Receptors, and Human Experimental Pain Models: Bridging the Gap between Target Discovery and Drug Development.
Raja SN; Sivanesan E; Guan Y
Anesthesiology; 2019 Aug; 131(2):233-235. PubMed ID: 31233408
[No Abstract] [Full Text] [Related]
3. Low doses of dextromethorphan have a beneficial effect in the treatment of neuropathic pain.
Morel V; Pickering G; Etienne M; Dupuis A; Privat AM; Chalus M; Eschalier A; Daulhac L
Fundam Clin Pharmacol; 2014 Dec; 28(6):671-80. PubMed ID: 24702319
[TBL] [Abstract][Full Text] [Related]
4. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia.
Nelson KA; Park KM; Robinovitz E; Tsigos C; Max MB
Neurology; 1997 May; 48(5):1212-8. PubMed ID: 9153445
[TBL] [Abstract][Full Text] [Related]
5. Dextromethorphan for the treatment of neuropathic pain: a double-blind randomised controlled crossover trial with integral n-of-1 design.
McQuay HJ; Carroll D; Jadad AR; Glynn CJ; Jack T; Moore AR; Wiffen PJ
Pain; 1994 Oct; 59(1):127-133. PubMed ID: 7854793
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the analgesic effect of dextromethorphan and its interaction with nitric oxide on sciatic nerve ligated rats.
Karimi G; Tabrizian K; Rezaee R
J Acupunct Meridian Stud; 2010 Mar; 3(1):38-42. PubMed ID: 20633514
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of dextromethorphan/quinidine at two dosage levels for diabetic neuropathic pain: a double-blind, placebo-controlled, multicenter study.
Shaibani AI; Pope LE; Thisted R; Hepner A
Pain Med; 2012 Feb; 13(2):243-54. PubMed ID: 22314263
[TBL] [Abstract][Full Text] [Related]
8. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain.
Ho KY; Huh BK; White WD; Yeh CC; Miller EJ
Clin J Pain; 2008 Jan; 24(1):51-5. PubMed ID: 18180637
[TBL] [Abstract][Full Text] [Related]
9. Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial.
Lynch ME; Clark AJ; Sawynok J; Sullivan MJ
Anesthesiology; 2005 Jul; 103(1):140-6. PubMed ID: 15983466
[TBL] [Abstract][Full Text] [Related]
10. Dextromethorphan-induced serotonin syndrome.
Schwartz AR; Pizon AF; Brooks DE
Clin Toxicol (Phila); 2008 Sep; 46(8):771-3. PubMed ID: 19238739
[TBL] [Abstract][Full Text] [Related]
11. Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study.
Thisted RA; Klaff L; Schwartz SL; Wymer JP; Culligan NW; Gerard G; Pope LE; Berg JE
Clin Ther; 2006 Oct; 28(10):1607-18. PubMed ID: 17157116
[TBL] [Abstract][Full Text] [Related]
12. Dextromethorphan poisoning reversed by naloxone.
Schneider SM; Michelson EA; Boucek CD; Ilkhanipour K
Am J Emerg Med; 1991 May; 9(3):237-8. PubMed ID: 2018593
[TBL] [Abstract][Full Text] [Related]
13. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.
Younger J; Noor N; McCue R; Mackey S
Arthritis Rheum; 2013 Feb; 65(2):529-38. PubMed ID: 23359310
[TBL] [Abstract][Full Text] [Related]
14. NMDA receptor antagonists for the treatment of neuropathic pain.
Collins S; Sigtermans MJ; Dahan A; Zuurmond WW; Perez RS
Pain Med; 2010 Nov; 11(11):1726-42. PubMed ID: 21044263
[TBL] [Abstract][Full Text] [Related]
15. MorphiDex (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance.
Galer BS; Lee D; Ma T; Nagle B; Schlagheck TG
Pain; 2005 Jun; 115(3):284-295. PubMed ID: 15911155
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition.
Schadel M; Wu D; Otton SV; Kalow W; Sellers EM
J Clin Psychopharmacol; 1995 Aug; 15(4):263-9. PubMed ID: 7593709
[TBL] [Abstract][Full Text] [Related]
17. Rationale and design of a randomized double-blind clinical trial in breast cancer: dextromethorphan in chemotherapy-induced peripheral neuropathy.
Martin E; Morel V; Joly D; Villatte C; Delage N; Dubray C; Pereira B; Pickering G
Contemp Clin Trials; 2015 Mar; 41():146-51. PubMed ID: 25636304
[TBL] [Abstract][Full Text] [Related]
18. Patient-tailored combinations of systemic and topical preparations for localized peripheral neuropathic pain: a two-case report.
Weinbroum AA; Zur E
J Pain Palliat Care Pharmacother; 2015 Mar; 29(1):27-33. PubMed ID: 25594152
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of a multicenter randomized clinical trial with memantine and dextromethorphan in ketamine-responder patients.
Pickering G; Pereira B; Morel V; Tiberghien F; Martin E; Marcaillou F; Picard P; Delage N; de Montgazon G; Sorel M; Roux D; Dubray C
Contemp Clin Trials; 2014 Jul; 38(2):314-20. PubMed ID: 24948402
[TBL] [Abstract][Full Text] [Related]
20. Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis.
Panitch HS; Thisted RA; Smith RA; Wynn DR; Wymer JP; Achiron A; Vollmer TL; Mandler RN; Dietrich DW; Fletcher M; Pope LE; Berg JE; Miller A;
Ann Neurol; 2006 May; 59(5):780-7. PubMed ID: 16634036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
